Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part D draft call letter withdrawn

Executive Summary

Although not a Federal Register-published regulation, following the president's memorandum asking agencies to freeze pending regs, CMS said Jan. 22 that it is withdrawing its draft call letter for Medicare Part C and Part D bids for the 2010 plan year. CMS issued the letter Jan. 8 (1"The Pink Sheet," Jan. 19, 2009, p. 13). The announcement says that once the letter is reviewed and any changes are made, it will be reposted on the CMS Web site for public comment "as soon as possible.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050594

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel